Company profile
Stablepharma Ltd company profile
Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines, therapeutics and diagnostics into fridge free thermostable products that do not require refrigeration to preserve them, thereby addressing the global challenges of the cold chain. Stablepharma’s R&D team have identified up to 60 vaccine candidates that could be suitable for StablevaX™ technology. The company actively collaborates with global vaccine manufacturers, academic institutions and NGOs, to advance their pipeline of thermostable products.
Business identity
- Website
- http://stablepharma.com/
- Contact email
- [email protected]
- Phone number
- +44 (0)1225 581 220
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2012-01-26
Headquarters
- Headquarters
- Burley, England, United Kingdom
- Postal code
- BA1 1HE
- Country code
- GB
- Continent
- Europe